Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Brain metastases admissions in Sweden between 1987 and 2006
British Journal of Cancer, 10/16/09
Smedby KE et al. – The number of patients admitted with BM has increased rapidly in Sweden. In spite of recent improvements in the prognosis of common primary cancer types, any parallel improvement among patients with advanced cancer and BM is not indicated.
Related Articles
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
Annals of Oncology, 10/21/09
Relevance Score: 71%
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology, 10/29/09
Relevance Score: 69%
Reirradiation for progressive brain metastases
Journal of Cancer Research and Therapeutics, 10/27/09
Relevance Score: 69%
Clinical Analysis of Novalis Stereotactic Radiosurgery for Brain Metastases
Journal of Korean Neurosurgical Society, 10/30/09
Relevance Score: 68%
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
The Lancet Oncology - Online First, 10/07/09
Relevance Score: 68%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Clinical Cancer Research, 12/01/09
High-risk neuroblastoma: a therapy in evolution
Pediatric Hematology and Oncology, 11/30/09
Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines
Pediatric Hematology and Oncology, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


